Novartis profits jump 12% on new drug sales

Last Updated: Tuesday, January 27, 2015, 16:17

Swiss pharmaceuticals giant Novartis said Tuesday strong sales of new products helped push its net profit up 12 percent last year despite harsh competition from cheaper copycat generic drugs.

Novartis okays OTC unit sale to GSK Consumer for Rs 109.7-cr

Last Updated: Tuesday, January 13, 2015, 19:15

Novartis India's board on Tuesday approved the sale of its OTC division to GlaxoSmithKline Consumer Pvt Ltd, a consumer healthcare joint venture between Novartis AG and GSK, for a consideration of Rs 109.7 crore.

Modi government clears FDI proposals worth Rs 1,827.24 crore

Last Updated: Saturday, January 10, 2015, 00:30

The Finance Ministry on Friday said it has cleared 12 FDI applications, including that of Ratnakar Bank to raise foreign equity limit to 74 percent, entailing total investment of Rs 1,827.24 crore.

HC order 'disappointing', says Cipla

Last Updated: Friday, January 9, 2015, 23:10

Drug maker Cipla Friday expressed disappointment over the Delhi High Court order that restrained the company from manufacturing and selling any medicine containing 'Indacaterol', saying that the interim verdict would deny patients access to drugs they need.

Novartis shares up nearly 2% at close

Last Updated: Wednesday, December 24, 2014, 13:59

Surrendering most of early gains in-line with a weak stock market, shares of Novartis India ended nearly 2 percent higher Wednesday, a day after fair trade regulator CCI approved a multi-billion dollar deal between global pharma giants GlaxoSmithKline Plc and Novartis.

CCI clears multi-billion Novartis-GSK pharma deal

Last Updated: Tuesday, December 23, 2014, 20:07

Fair trade regulator CCI has approved a multi-billion dollar deal between global pharma giants GlaxoSmithKline Plc and Novartis, as it did not find the transaction to be anti-competitive ion India.

Dr Reddy's acquires Habitrol brand

Last Updated: Friday, December 19, 2014, 16:02

City-based drugmaker Dr Reddy's Laboratories has acquired Habitrol brand, a nicotine replacement therapy transdermal patch, from Novartis Consumer Health Inc.

HC reserves order on Novartis-Cipla drug dispute

Last Updated: Wednesday, December 17, 2014, 21:32

The Delhi High Court has reserved its verdict on a dispute between pharma firms Novartis and Cipla over manufacturing of the drug Indacaterol, used for treatment of chronic obstructive pulmonary disease.

Novartis sues India's Cipla over respiratory drug Onbrez

Last Updated: Wednesday, December 17, 2014, 19:21

Swiss drugmaker Novartis AG said on Wednesday it had sued India`s Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug`s price.

Novartis to cut or transfer up to 4,000 pharma jobs: Paper

Last Updated: Sunday, February 2, 2014, 16:34

The plan affecting up to 6 percent of its pharmaceuticals workforce comes on top of a programme to reduce the number of production sites and is part of a larger drive to cut costs, the newspaper said.

Japan files criminal complaint against Novartis arm

Last Updated: Thursday, January 9, 2014, 10:06

Japan`s health ministry on Thursday filed a criminal complaint against the local arm of Swiss pharmaceutical giant Novartis over alleged exaggerated advertising for a popular blood-pressure drug, the company said.